Cardiovascular Drugs: Classification based on Therapeutic Indications
Classification of Systems-I
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jun 6, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Tapan Kumar Behera1, Siddhartha Sathia2, Sibarama Panigrahi3
1Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Burla, Sambalpur, Odisha, India.
机器学习 (ML) 模型为心血管疾病 (CVD) 提供了具有成本效益的数字诊断. 额外树分类器在准确性和精确性方面表现出色,而XGBoost在CVD分类的回忆,kappa和F1分数方面处于领先地位.
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: